We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Tissue Resector Helps Remove Uterine Polyps

By HospiMedica International staff writers
Posted on 13 Jul 2016
A disposable hand-held and hand-driven device combines the benefits of basic manual devices and complex electromechanical systems in uterine polyp removal.

The RESECTR is a manual surgical instrument with an innovative cutting tip, a novel tissue aspiration mechanism, and a unique blade oscillator. Starting right at the cutting tip, the aspiration pulls tissue samples into a serrated window, where the oscillating blades (controlled by the clinician’s index finger and hand), spin both clockwise and counterclockwise to cut the tissue. The clinician has the ability to increase or decrease oscillation and cutting, based on visual and tactile information during the procedure.

Device control, positioning, tissue aspiration, and cutting are all done with one hand actuation; each time the physician squeezes the device handle, a new level of control and feel is induced. The RESECTR device, a product of Distal Access (Park City, UT, USA), has been approved by the U.S. Food and Drug Administration (FDA), and is compatible with available fluid management systems and hysteroscopic and endoscopic devices.

“The RESECTR is designed to improve safety, speed, and control during tissue resection,” said Chris Livingstone, vice president of sales and marketing at Distal Access. “Patients are the real winners here as the RESECTR can help clinicians ‘see-and-treat’ lesions in the hospital, clinic, or physician office. We look forward to seeing this tool help patients during a variety of procedures.”

“The system was easy to use; it allowed me to access the lesion and completely remove the polyp with precision and speed,” said gynecology and reproductive endocrinology surgeon Keith Isaacson, MD, of Newton-Wellesley Hospital (Newton, MA, USA), who was the first to use the RESECTR. “It provides a benefit to patients in that the entire polyp can be removed under direct visualization in a very short period of time without the risk of bleeding or uterine perforation.”

Related Links:
Distal Access



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Needle-Free IV Connector Technology
Clave
New
Prostate Cancer MRI Analysis Tool
DynaCAD Urology
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The novel approach utilizes continuous glucose monitoring to detect early signs of impaired glucose regulation (Photo courtesy of Shinya Kuroda/University of Tokyo)

Wearable Glucose Monitor Offers Less Invasive Approach to Assessing Diabetes Risk

Diabetes, often referred to as a "silent epidemic," is a growing global health issue with significant impacts on both health and the economy. Detecting impaired glucose regulation early — an intermediate... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.